Zydus Life Science Quarterly Results for Trading Insights

ZYDUSLIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,239 Cr
QSept 2025
Quarterly Results

Zydus Life Science Quarterly Results Key Highlights

  • Revenue of ₹6,147 Cr in Sept 2025 (-3.5% vs Mar 2025, +18.6% vs Sept 2024)
  • Net Profit of ₹1,239 Cr in Sept 2025 (-0.4% vs Mar 2025, +34.7% vs Sept 2024)
  • EBITDA of ₹2,005 Cr in Sept 2025 (+14.6% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+4.0pp vs Mar 2025)
  • Earnings Per Share of ₹12.51 in Sept 2025 (+7.5% vs Mar 2025)

Zydus Life Science Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 6,147 6,371 6,622 6,892 5,182 -3.5% 18.6%
Net Profit (₹ Cr) 1,239 1,244 1,521 1,023 920 - -
EBITDA (₹ Cr) 2,005 1,749 2,137 1,759 1,407 - -
EPS (₹) 12.51 11.64 14.58 10.36 9.06 - -
Operating Margin (%) 31.0% 27.0% 31.0% 24.0% 26.0% - -

Zydus Life Science Share Price Trend Around Quarterly Results

Visualize Zydus Life Science's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Zydus Life Science

Additional stock information and data for ZYDUSLIFE

ZYDUSLIFE stock price BSE
ZYDUSLIFE price earnings ratio
ZYDUSLIFE price range

Profitability Ratios

Profit Margin 20.2%
EBITDA Margin 32.6%
Operating Margin 31.0%
ROE (Annual) 18.8%

Balance Sheet Highlights

Total Assets ₹37,202 Cr
Total Equity ₹26,358 Cr
Current Assets ₹17,046 Cr
Current Liabilities ₹1,802 Cr

Cash Flow Analysis

Operating Cash Flow ₹6,777 Cr
Investing Cash Flow ₹-8,377 Cr
Financing Cash Flow ₹2,014 Cr
Net Cash Flow ₹414 Cr

Current Market Data

Current Price ₹873.50
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 6,892
Jun 2025 6,622
Mar 2025 6,371
Sept 2025 6,147

Net Profit Trend (₹ Cr)

Dec 2025 1,023
Jun 2025 1,521
Mar 2025 1,244
Sept 2025 1,239

Operating Margin Trend (%)

Dec 2025 24.0%
Jun 2025 31.0%
Mar 2025 27.0%
Sept 2025 31.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Zydus Life Science quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1196.1 9,135 1,337 +1.1% - 14.6% 73.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores